TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Newbridge Financial Services Group, Inc. | 2 | $1 | 0.00% |
Westside Investment Management, Inc. | 4 | $2 | 0.00% |
Global Wealth Strategies & Associates | 40 | $19 | 0.00% |
Cape Investment Advisory, Inc. | 1 | $0 | 0.00% |
JPMORGAN CHASE & CO | 157 | $73 | 0.00% |
Nemes Rush Group LLC | 1 | $1 | 0.00% |
Renaissance Technologies | 135,710 | $64 | 0.00% |
VANGUARD GROUP INC | 82,051 | $38,892 | 0.00% |
UBS Group AG | 4 | $2 | 0.00% |
OSAIC HOLDINGS, INC. | 50 | $22 | 0.00% |